Editors' ChoiceCancer

An EVolving approach to directed enzyme prodrug therapy for cancer

See allHide authors and affiliations

Science Translational Medicine  21 Mar 2018:
Vol. 10, Issue 433, eaat1642
DOI: 10.1126/scitranslmed.aat1642

You are currently viewing the abstract.

View Full Text

Abstract

Gene-directed enzyme prodrug therapy for cancer is made more specific via targeted extracellular vesicle-mediated mRNA delivery.

View Full Text